RESEARCH
PUBLICATIONS
NEXTBIO COMMUNITY
|
|
|
-
IRX-2 and thymosin alpha1 (Zadaxin) increase T lymphocytes in T lymphocytopenic mice and humans.
Authors: J W Hadden, E Verastegui, E Hadden
Annals of the New York Academy of Sciences 2007 Sep -
Thymosin alpha 1 activates dendritic cells for antifungal Th1 resistance through toll-like receptor signaling.
Authors: Luigina Romani, Francesco Bistoni, Roberta Gaziano, Silvia Bozza, Claudia Montagnoli, Katia Perruccio, Lucia Pitzurra, Silvia Bellocchio, Andrea Velardi, Guido Rasi,…
Blood 2004 Jun 1
Thought leaders and organizations working on research involving Zadaxin.
- Herlev Hospital
- sigma-tau i.f.r. S.p.A.
- Sun Yat-sen University
- Banaras Hindu University
- Zhejiang University
- University of Tokyo
- Chang Gung University and Memorial Hospital
- Georgetown University Medical Center
-
Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma
conditions: Malignant Melanoma
interventions: Dacarbazine + Interferon alpha + Thymosin-alpha-1 1.6 mg ; Dacarbazine + Interferon alpha + Thymosin-alpha-1 3.2 mg ; Dacarbazine + Interferon alpha + Thymosin-alpha-1 6.4 mg ; Dacarbazine + Thymosin-alpha-1 3.2 mg ; Dacarbazine + Interferon alpha
-
Dendritic Cell Based Therapy for Breast Cancer Patients
conditions: Breast Cancer
interventions: DC vaccine ; Exemestane
-
SciClone stock surges on Zadaxin news
FierceVaccines. - January 12, 2010 -
SciClone And Sigma-Tau Announce Additional Positive Results In Clinical Study Examining ZADAXIN's Ability To Enhance Response To H1N1 Vaccine
Medical News Today. - February 08, 2010
Community
